Beyond Air Inc.

  • Home
  • About Us
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
  • Pipeline
    • Overview
    • PPHN
    • Viral Lung Infections
    • Nontuberculous Mycobacteria (NTM)
    • Solid Tumors
  • News & Events
    • Press Releases
    • Presentations
    • Publications
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact

Press Releases

Investors

Investors

  • Overview
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar

Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022

May 17, 2022 4:05pm EDT

Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer

May 17, 2022 7:00am EDT

Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast

May 16, 2022 7:05am EDT

Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022

Apr 25, 2022 4:05pm EDT

Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022

Apr 25, 2022 7:00am EDT

Beyond Air® to Participate in Three Upcoming Medical Conferences

Apr 18, 2022 7:00am EDT

Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect

Apr 11, 2022 7:00am EDT

Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting

Mar 08, 2022 4:35pm EST

Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022

Feb 10, 2022 4:05pm EST

Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022

Feb 08, 2022 8:00am EST
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...17
Next
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Important Safety Information

†Caution - LungFit is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use.

© 2022 Beyond Air Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Search